Módulo 2 – teoría
Técnicas de administración

6. Bibliografía

  • Aragón Alonso A, Olivan Palacios B, Manzano Arroyo P, Lucas Morante T. Información terapéutica del Sistema Nacional de Salud. 2004. Vol. 28, Nº 2.
  • Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013. http://dx.doi.org/10.1016/j.diabet.2013.05.006
  • Estrategia secuencial de insulinización en la DM2. ADA/EASD 2016. American Diabetes Association Diabetes Care. January 2016;39(Supplement 1).
  • Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. J Gerontol A Biol Sci Med Sci. 2004;59(3):255-65.
  • Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. Lancet. 2014;384:2228-34. http://dx.doi.org/10.1016/S0140-6736(14)61335-0.
  • Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, et al. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin. 2008;24:275-86.
  • Mullins P, et al. ¿NPH o análogo basal? Clin Ther. 2007;29:1607-19.
  • New injection recommendations for patients with diabetes. Scientific Advisory Board for the Third Injection technique Workshop. Diabetes Metab. 2010;36(supp. 1):S3-18 (ITQ).
  • New Insulin Delivery Recommendations. © 2016 Mayo Foundation for Medical Education and Research. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Mayo Clin Proc. 2016;91(9):1231-1255.
  • Planes de Cuidados Enfermeros en la Diabetes tipo 1 y 2. Procesos Asistenciales Integrados. Consejería de Salud. Junta de Andalucía. 2006. www.csalud.junta-andalucia.es/contenidos/procesos/docs
  • Salvador J, Andrade P. Efectos extrapancreáticos de los agonistas del receptor de GLP-1: una ventana hacia nuevos objetivos del tratamiento farmacológico de la diabetes mellitus tipo 2. Med Clin. 2014;143:28-34.
  • Vidal M, et al. Actualización sobre técnicas y sistemas de administración de la insulina (I). Av Diabetol. 2008;24:175-90.
  • WISE recommendations to ensure the safety of injections in diabetes. Diabetes & Metabolism 38 (2012) S2-S8.
  • Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional. © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Mayo Clin Proc. 2016;91(9):1224-1230.
  • Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices. © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Mayo Clin Proc. 2016;91(9):1212-1223.